Endoscopic Ultrasound Market Report: Trends, Forecast and Competitive Analysis to 2031

Endoscopic Ultrasound Market Trends and Forecast

The future of the global endoscopic ultrasound market looks promising with opportunities in the hospital and ambulatory surgical center markets. The global endoscopic ultrasound market is expected to grow with a CAGR of 6.8% from 2025 to 2031. The major drivers for this market are the increasing prevalence of gastrointestinal diseases, the rising demand for minimally invasive diagnostic procedures, and the growing adoption of advanced imaging technologies.

• Lucintel forecasts that, within the product category, needle is expected to witness the highest growth over the forecast period.

• Within the end use category, ambulatory surgical center is expected to witness higher growth.

• In terms of region, APAC is expected to witness the highest growth over the forecast period. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Endoscopic Ultrasound Market

The endoscopic ultrasound market is experiencing a profound transformation, driven by an accelerating need for highly accurate, minimally invasive diagnostic and therapeutic tools. These emerging trends reflect a concerted global effort to enhance clinical capabilities, improve patient comfort, and integrate advanced technologies for more precise and effective healthcare delivery.

• Integration of Artificial Intelligence: AI algorithms are being integrated into EUS systems to enhance image interpretation, improve diagnostic accuracy, and assist in lesion characterization. This trend aims to reduce inter-operator variability, streamline workflows, and enable earlier detection of subtle abnormalities, leading to more precise diagnoses and treatment plans.

• Development of Single-Use EUS Scopes: The demand for single-use EUS endoscopes is increasing to mitigate the risk of cross-contamination and simplify reprocessing procedures. This trend offers enhanced patient safety and reduces the burden of complex disinfection protocols for healthcare facilities, although the cost implications remain a factor.

• Enhanced Therapeutic Capabilities: EUS is evolving beyond diagnostic imaging to become a therapeutic tool, with advancements in EUS-guided interventions like pseudocyst drainage, celiac plexus block, and tumor ablation. This trend expands the utility of EUS, enabling minimally invasive treatment options for various conditions, improving patient recovery times.

• Miniaturization and Portability: Manufacturers are developing smaller, more portable EUS systems, making the technology more accessible in various clinical settings, including ambulatory surgical centers and outpatient clinics. This trend allows for greater flexibility in care delivery and can potentially reduce healthcare costs by shifting procedures away from traditional hospital settings.

• Improved Elastography and Contrast-Enhanced EUS: Advancements in elastography (measuring tissue stiffness) and CE-EUS (using contrast agents to highlight tissue perfusion) are providing more detailed and functional information. These techniques enhance the ability to differentiate between benign and malignant lesions, leading to more accurate staging and targeted interventions. These trends are profoundly reshaping the endoscopic ultrasound market by pushing the boundaries of diagnostic precision and therapeutic intervention. They are fostering a new generation of EUS systems that are more intelligent, safer, and versatile, ultimately improving patient care, streamlining clinical workflows, and expanding the reach of this critical medical technology.

Recent Development in the Endoscopic Ultrasound Market

The endoscopic ultrasound market is witnessing a wave of innovation and expansion, driven by the increasing global burden of gastrointestinal and pulmonary diseases and the demand for advanced diagnostic and therapeutic tools. These developments are enhancing the precision, safety, and versatility of EUS procedures.

• Technological Advancements in Imaging: Recent developments include higher-resolution transducers, enhanced image processing software, and the integration of modalities like elastography and contrast-enhanced EUS. These innovations provide clearer, more detailed images, enabling better visualization of lesions and more accurate tissue characterization, crucial for early diagnosis and staging.

• Expansion of EUS-Guided Interventions: EUS is increasingly being utilized for therapeutic procedures beyond just diagnosis. Developments include advanced EUS-guided fine-needle aspiration (FNA) and fine-needle biopsy (FNB) tools, as well as novel techniques for pseudocyst drainage, celiac plexus neurolysis, and even anti-tumor therapies, broadening its clinical utility.

• Introduction of Single-Use Endoscopes: To address concerns about reprocessing safety and cross-contamination, manufacturers are developing single-use EUS endoscopes. This development aims to enhance patient safety and streamline clinical workflows by eliminating the need for complex disinfection procedures, though cost considerations are still being evaluated.

• Growing Adoption of AI and Machine Learning: Artificial intelligence and machine learning algorithms are being integrated into EUS systems to assist in real-time image analysis and interpretation. This development promises to improve diagnostic accuracy, reduce operator dependency, and potentially identify subtle abnormalities that might be missed by the human eye.

• Strategic Collaborations and Partnerships: Leading medical device companies are forming strategic alliances and collaborations to accelerate research and development, enhance training programs, and expand market reach. These partnerships foster innovation and facilitate the wider adoption of advanced EUS technologies globally. These developments are significantly impacting the endoscopic ultrasound market by enhancing diagnostic capabilities, expanding therapeutic applications, improving patient safety, and fostering a more technologically advanced and interconnected clinical landscape. This ultimately translates to better patient care and more efficient healthcare delivery.

Strategic Growth Opportunities in the Endoscopic Ultrasound Market

The endoscopic ultrasound market presents significant strategic growth opportunities across various key applications, driven by the rising prevalence of chronic diseases and the increasing demand for minimally invasive procedures. These opportunities highlight avenues for innovation and market expansion for EUS manufacturers and service providers.

• Oncology: EUS is crucial for accurate staging of gastrointestinal, pancreatic, and lung cancers. Developing enhanced EUS-guided biopsy tools (FNA/FNB) and incorporating AI for precise tumor delineation offers immense growth. This addresses the critical need for early detection and personalized cancer treatment strategies.

• Pancreaticobiliary Disorders: EUS is indispensable for diagnosing and managing conditions like pancreatitis, bile duct stones, and pancreatic cysts. Growth opportunities lie in developing specialized EUS catheters for drainage procedures, advanced imaging for early lesion detection, and integrated therapeutic platforms for minimally invasive interventions, improving patient outcomes.

• Pulmonology: EUS, particularly Endobronchial Ultrasound (EBUS), is vital for staging lung cancer and diagnosing mediastinal lymphadenopathy. Focusing on improved EBUS scopes, advanced needle designs for lymph node biopsy, and integration with navigational bronchoscopy systems offers significant growth in respiratory diagnostics.

• Gastrointestinal Submucosal Lesions: EUS plays a crucial role in evaluating submucosal lesions in the GI tract. Opportunities include developing EUS-guided resection techniques for these lesions, enabling minimally invasive removal. This expands EUS from purely diagnostic to a highly effective therapeutic tool for early-stage lesions.

• EUS-Guided Interventional Procedures: Beyond diagnostic applications, EUS-guided interventions for various conditions (e.g., celiac plexus neurolysis for pain, pseudocyst drainage, fiducial placement for radiation therapy) represent a high-growth area. Investing in training, specialized accessories, and integrated platforms for these advanced procedures can unlock substantial market value. These strategic growth opportunities are poised to profoundly impact the endoscopic ultrasound market by driving product innovation, expanding clinical utility beyond traditional diagnostics, and fostering the development of specialized therapeutic interventions. This will ultimately lead to more effective, minimally invasive treatment options for a wider range of patients.

Endoscopic Ultrasound Market Driver and Challenges

The endoscopic ultrasound market is shaped by a complex interplay of forces. Major drivers include various technological advancements, the escalating prevalence of chronic gastrointestinal diseases, and the global push for minimally invasive diagnostic and therapeutic procedures. Conversely, significant challenges encompass the high cost of equipment, the need for highly specialized training, and stringent regulatory hurdles, collectively influencing market dynamics. The factors responsible for driving the endoscopic ultrasound market include: 1. Increasing Prevalence of Gastrointestinal Diseases: The rising incidence of conditions like pancreatic cancer, esophageal cancer, and bile duct disorders globally is a primary driver. EUS offers superior imaging and diagnostic capabilities for these diseases, leading to increased demand for early and accurate diagnosis and staging. 2. Growing Preference for Minimally Invasive Procedures: Patients and healthcare providers increasingly favor minimally invasive techniques due to reduced pain, shorter hospital stays, and faster recovery times. EUS, being a minimally invasive procedure, aligns with this trend, driving its adoption over more invasive surgical options. 3. Technological Advancements: Continuous innovations in EUS technology, such as higher-resolution imaging, real-time elastography, contrast-enhanced EUS, and the development of more sophisticated EUS-guided therapeutic tools, enhance diagnostic accuracy and expand clinical applications, boosting market growth. 4. Rising Geriatric Population: The global aging population is more susceptible to various chronic diseases, including gastrointestinal cancers and pancreatic conditions. This demographic shift naturally increases the demand for diagnostic and therapeutic procedures like EUS, contributing to market expansion. 5. Increasing Awareness and Adoption: Growing awareness among healthcare professionals about the benefits and expanded capabilities of EUS, coupled with increased training initiatives, is leading to broader adoption of the technology in hospitals and specialized clinics worldwide. Challenges in the endoscopic ultrasound market are: 1. High Cost of Equipment: The initial capital expenditure for EUS systems, including the endoscopes, ultrasound processors, and specialized accessories, is substantial. This high cost can be a barrier for smaller hospitals or clinics, particularly in developing regions, limiting wider adoption. 2. Need for Highly Skilled Professionals: Performing and interpreting EUS procedures requires extensive training, specialized skills, and considerable experience. The scarcity of adequately trained gastroenterologists and pulmonologists with EUS expertise can hinder the widespread implementation and utilization of these systems. 3. Stringent Regulatory Approvals: Medical devices, especially complex diagnostic and therapeutic systems like EUS, are subject to rigorous regulatory approval processes in various countries. Navigating these lengthy and costly approval pathways can delay market entry for new products and innovations. The endoscopic ultrasound market is propelled by critical drivers such as the escalating burden of gastrointestinal diseases and continuous technological innovations, enhancing diagnostic and therapeutic precision. However, overcoming significant challenges related to high equipment costs, the demand for specialized training, and stringent regulatory frameworks will be essential for sustained growth and broader global accessibility of EUS.

List of Endoscopic Ultrasound Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies endoscopic ultrasound companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the endoscopic ultrasound companies profiled in this report include-

• Boston Scientific Corporation

• Medtronic

• ConMed

• Olympus Corporation

• Steris

• SonoScape Medical

• PENTEX Medical

• FUJIFILM India Private Limited

• Cook Medical

• Medi-Globe

Endoscopic Ultrasound Market by Segment

The study includes a forecast for the global endoscopic ultrasound market by product, application, end use, and region.

Endoscopic Ultrasound Market by Product [Value from 2019 to 2031]:

• Endoscope

• Ultrasound Probe

• Needle

• Accessories

• Ultrasonic Processors

Endoscopic Ultrasound Market by Application [Value from 2019 to 2031]:

• Gastrointestinal Cancer

• Lung Cancer

• Pancreaticobiliary Disease

• Others

Endoscopic Ultrasound Market by End Use [Value from 2019 to 2031]:

• Hospitals

• Ambulatory Surgical Center

• Others

Endoscopic Ultrasound Market by Region [Value from 2019 to 2031]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

Country Wise Outlook for the Endoscopic Ultrasound Market

The endoscopic ultrasound market is experiencing significant growth, driven by its pivotal role in diagnosing and staging various gastrointestinal and pulmonary conditions, particularly cancers. Ongoing technological advancements, including enhanced imaging and therapeutic capabilities, are continuously improving patient outcomes and expanding the clinical utility of EUS globally.

• United States: The US market is characterized by rapid adoption of advanced EUS technologies, especially EUS-guided fine-needle aspiration (FNA) and fine-needle biopsy (FNB). High incidence of gastrointestinal cancers, favorable reimbursement policies, and strategic collaborations for training are propelling market expansion and enhancing diagnostic accuracy.

• China: China's EUS market is witnessing substantial growth, fueled by increasing prevalence of gastrointestinal disorders and government initiatives to improve healthcare infrastructure. Local manufacturers and international players are focusing on expanding accessibility to EUS procedures, with a notable increase in the number of EUS-equipped hospitals and trained endoscopists.

• Germany: Germany's EUS market emphasizes high-quality and precise diagnostic and therapeutic capabilities. With a well-established healthcare system and a high incidence of chronic diseases, there's a steady demand for advanced EUS systems. Focus on technological innovation and clinical research drives adoption in this mature European market.

• India: India's EUS market is experiencing significant growth, primarily due to the increasing awareness of gastrointestinal health and rising prevalence of related disorders. Investments in healthcare infrastructure, particularly in urban areas, and a push for less invasive procedures are driving the adoption of EUS systems and related accessories.

• Japan: Japan's EUS market is dominated by key domestic players like Olympus and Fujifilm, focusing on precision and integrated diagnostic solutions. Strategic alliances, such as between Olympus and Hitachi, are common for joint development of advanced EUS systems, reflecting a commitment to innovation and high-quality medical technology.

Features of the Global Endoscopic Ultrasound Market

Market Size Estimates: Endoscopic ultrasound market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions. Segmentation Analysis: Endoscopic ultrasound market size by product, application, end use, and region in terms of value ($B). Regional Analysis: Endoscopic ultrasound market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different products, applications, end uses, and regions for the endoscopic ultrasound market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the endoscopic ultrasound market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the growth forecast for endoscopic ultrasound market? Answer: The global endoscopic ultrasound market is expected to grow with a CAGR of 6.8% from 2025 to 2031. Q2. What are the major drivers influencing the growth of the endoscopic ultrasound market? Answer: The major drivers for this market are the increasing prevalence of gastrointestinal diseases, the rising demand for minimally invasive diagnostic procedures, and the growing adoption of advanced imaging technologies. Q3. What are the major segments for endoscopic ultrasound market? Answer: The future of the endoscopic ultrasound market looks promising with opportunities in the hospital and ambulatory surgical center markets. Q4. Who are the key endoscopic ultrasound market companies? Answer: Some of the key endoscopic ultrasound companies are as follows:

• Boston Scientific Corporation

• Medtronic

• ConMed

• Olympus Corporation

• Steris

• SonoScape Medical

• PENTEX Medical

• FUJIFILM India Private Limited

• Cook Medical

• Medi-Globe Q5. Which endoscopic ultrasound market segment will be the largest in future? Answer: Lucintel forecasts that, within the product category, needle is expected to witness the highest growth over the forecast period. Q6. In endoscopic ultrasound market, which region is expected to be the largest in next 5 years? Answer: In terms of region, APAC is expected to witness the highest growth over the forecast period. Q7. Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.